Thursday, March 21, 2013

VETERANS DISCUSSION

You are subscribed to Defense News Lead Photo for U.S. Department of Defense. This information has recently been updated, and is now available.
03/21/2013 03:44 PM CDT

Defense Secretary Chuck Hagel, left center, conducts a round-table discussion with representatives of veterans service organizations at the Pentagon, March 21, 2013.
Updates from the U.S. Department of Defense

HAGEL ROUND TABLE

You are subscribed to Defense News Lead Photo for U.S. Department of Defense. This information has recently been updated, and is now available.
03/21/2013 03:44 PM CDT

Defense Secretary Chuck Hagel, left, conducts a round-table discussion with representatives of veterans service organizations at the Pentagon, March 21, 2013.
Updates from the U.S. Department of Defense

NSF Releases Response to External Panel's Recommendations for Streamlining Scientific Logistics in Antarctica

You are subscribed to News - All NSF News for National Science Foundation Update. This information has recently been updated, and is now available.

03/21/2013 02:00 PM EDT

Graphic illustration showing conceptual long-term plan for McMurdo Station at South Pole

The National Science Foundation (NSF) has issued a summary response to the recommendations of an external panel of experts that was charged with advising the agency on how to improve and streamline its logistical capabilities to more efficiently support world-class Antarctic science in coming decades.

The NSF document, which was made public on March 21, ...

More at http://www.nsf.gov/news/news_summ.jsp?cntn_id=127345&WT.mc_id=USNSF_51&WT.mc_ev=click


This is an NSF News item.

 


This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: National Science Foundation Update · 4201 Wilson Boulevard · Arlington, VA 22230 · 703-292-5111 Powered by GovDelivery

Digitial Press Kit: World TB Day

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

World TB Day: New U.S. Data for 2012

In advance of World TB Day, CDC has released preliminary national TB surveillance data for 2012. The new data show that after 20 consecutive years of declines, TB is at an all-time low in the United States.

  • Despite this progress, we must continue to address TB among disproportionately-affected communities, especially among racial/ethnic minorities and foreign-born individuals.
  • Drug-resistant TB currently accounts for a small proportion of overall TB cases; however, it still remains a serious threat to our ability to treat and control TB, both in the U.S. and abroad.
  • Although TB prevention and control efforts have averted an estimated more than 200,000 TB cases in the U.S. over the past 20 years, we must remain vigilant against this serious disease.

One way people can protect themselves from TB is by understanding what TB is and how it is spread. If you think you have been exposed to someone with TB disease, you should contact your doctor or local health department about getting a TB skin test or a special TB blood test.

Read more.


This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: Centers for Disease Control and Prevention (CDC) · 1600 Clifton Rd · Atlanta, GA 30333 · 1-800-CDC-INFO (800-232-4636) Powered by GovDelivery

New Chapter, Inc. Issues Voluntary Recall Undeclared soy identified in one lot of Probiotic Elderberry dietary supplement

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

03/20/2013 07:11 PM EDT

New Chapter, Inc. is voluntarily recalling a limited number of packages of its 90 count Probiotic Elderberry dietary supplement because it may contain an undeclared allergen - soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product. 

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.


This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

La Preferida, Inc. Issues A Voluntary Recall Of La Preferida Whole Pinto Beans 29 OZ. (Water & Salt)

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

03/20/2013 03:04 PM EDT

La Preferida, Inc. is voluntarily recalling 4,734 cases (56,808 cans) of La Preferida Whole Pinto Beans 29 oz. (Water & Salt). Can Code: PINTO LP, BEST BY 01/03/2015, “Time” 3003. The manufacturer’s preliminary inspection indicates 420 cans may not have been fully processed, which could result in product contamination by spoilage organisms or by pathogens, which could lead to illness if consumed.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.


This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Clinical Specialties Compounding Pharmacy Announces Voluntary Nationwide Recall of All lots of Sterile Products Repackaged and Distributed by Clinical Specialties Compounding Due to Lack of Sterility Assurance

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

03/20/2013 09:22 PM EDT

Clinical Specialties is voluntarily recalling All Lots of All Sterile products repackaged and distributed by the pharmacy due to lack of sterility assurance. The recall of all sterile products is conducted in follow-up to concerns regarding practices at the site which cannot assure the sterility of the products. The expanded recall follows the firm’s initial recall of Avastin due to reports of five patients who have been diagnosed with serious eye infections associated with the use of the product. 

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.


This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery